Someone else already paid for the growth: management describes an outside party bearing the cost, risk, or work that exp
The model's full reasoning — Q4 2022 call → NOWe need to determine if management describes an outside party bearing cost/risk/work of expanding the company's business, with real effort underway, cost on other side, payoff mostly ahead. Key points from transcript: - Partnerships with five companies, expect milestone payments. But that's just payments, not necessarily expansion. - Royalty sale to Royalty Pharma: they sold future royalties for $250M upfront. That's financing, not outside party expanding business. It's monetizing future revenue, not someone else building the business. - Takeda partnership for fazirsiran: Takeda is running Phase 3? Actually, Takeda submitted Phase 3 protocol, will begin Phase 3. Arrowhead and Takeda together. But is Takeda bearing cost? Yes, Takeda is partner, but does management convey that Takeda is doing the work to expand? They are co-developing. But the question is about outside party bearing cost/risk/work to expand the company's business. Takeda is a partner, but Arrowhead is also doing work. The transcript says "Takeda is still on schedule to begin the Phase 3 study" - that's Takeda's effort. But is that expansion of Arrowhead's business? It's a partnered program, so Arrowhead gets milestones/royalties. But the outside party is bearing cost of development. However, is that "real and underway now" and "payoff mostly ahead"? Yes, Phase 3 not started yet, but planned. But is it described as outside party bearing cost? They mention Takeda submitted protocol, will begin Phase 3. That implies Takeda is doing the work. But does management convey that this is expanding the company's business? It's a partnered program, so Arrowhead gets milestones. But the question asks: "does management describe that an outside party is already bearing the cost, risk, or work of expanding this company's business" - Takeda is bearing cost of Phase 3, but that's for a partnered drug. Arrowhead's business includes that. However, the emphasis is on "expanding this company's business" - meaning growth. Takeda is doing the heavy lifting for fazirsiran. But is that the main theme? Also, they have multiple partnerships. But the question is specific: "ONE coherent phenomenon: the growth in front of the company is being financed or executed substantially by others." Look for other examples: They have partnered programs, but they also have wholly-owned programs.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| IMAX | IMAX Corporation | Q2 2023 | 2023-07-26 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| VVV | Valvoline Inc. | Q1 2022 | 2022-02-09 | C+ |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PCRX | Pacira BioSciences, Inc. | Q4 2017 | 2018-02-28 | C |
| INST | Instructure's | Q4 2017 | 2018-02-12 | B+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| SNA | Snap-on Incorporated | Q3 2017 | 2017-10-19 | B |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| MGNX | MacroGenics, Inc. | Q3 2016 | 2016-11-02 | D |
| CRIS | Curis, Inc. | Q1 2016 | 2016-05-09 | C |
INST · Q4 2017 → YESThe question is about whether management describes an outside party already bearing the cost, risk, or work of expanding the company's business, with the effort real and underway now, but the resultin...YES The transcript shows management describing the Paychex partnership as a white-label reseller arrangement where Paychex is already bearing the cost, risk, and work of expanding Instructure’s business by offering Bridge Learn to its 0.5 million customers (6 million users) using its own salesforce and customer base — a real, underway effort since the partnership was entered into and integration is already in progress. Management explicitly states Paychex owns the customers and will sell the product, while Instructure is only powering the backend, and the resulting revenue is still mostly ahead (they are optimistic about significant success by year-end). This matches 100% of the required criteria.
PLAB · Q2 2017 → YESThe question is about whether management describes an outside party already bearing the cost, risk, or work of expanding the company's business, with the effort real and underway now, but the resultin...YES The transcript shows management describing the DNP JV as an outside party already bearing the bulk of the expansion costs and risks for the new China facility (the $160 million Xiamen site, previously announced as a company-led greenfield build last August). Peter Kirlin notes they will "utilize all cash held in Taiwan and greater reduced to risk of ramping of our new factory in China," while Sean Smith confirms they are "sharing that total investment of 160 million as we in essence have a 50-50 partnership, however we will consolidate it" and will "share equitably the startup cost.
YUM · Q2 2018 → YESThe question is about whether management describes an outside party already bearing the cost, risk, or work of expanding the company's business, with the effort real and underway now, but the resultin...YES The transcript shows management describing real, ongoing outside efforts by franchisees and partners already bearing the cost, risk, and work of expansion. Franchisees are actively spending their own capital to open units (e.g., 482 net new units YTD vs. 317 last year; KFC opening nearly 200 2Q units; Pizza Hut 6% net new unit growth; Taco Bell 9 international units), with the company 97% franchised and on track for 98%. These efforts are already in motion and contributing to current results, while management highlights acceleration and future ramp (e.g.